Search

Search Constraints

You searched for: Author/Creator Caillo, Ludovic

Search Results

1. An Anti-migration Self-expandable and Removable Metal Stent for Crohn's Disease Strictures: A Nationwide Study From GETAID and SFED. (27th October 2020)

2. Anti‐TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Issue 8 (7th September 2018)

3. Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus. Issue 1 (January 2021)

4. Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti‐TNF agent: a multicentre cohort study. Issue 9 (22nd March 2020)

5. Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. Issue 1 (January 2023)

6. Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID. Issue 9 (September 2022)

7. Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Issue 4 (April 2021)

8. Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent. Issue 6 (19th November 2022)

9. The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease. (27th November 2020)

10. Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID. (19th November 2020)